Jeevan Scientific Technology Limited

Equities

JSTL6

INE237B01018

Biotechnology & Medical Research

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-05-31 am EDT			5-day change	1st Jan Change
49.57 ^INR	+1.08%		+2.86%	-19.24%

Mar. 11	Jeevan Scientific Technology Limited Announces Executive Changes, Effective March 31, 2024	CI
Feb. 26	US FDA Clears Jeevan Scientific Technology's Bioanalytical Plant in Hyderabad, India	MT

Jeevan Scientific Technology Limited Announces Resignation of Srikanth Sasidhar as Chief Financial Officer

July 06, 2022 at 07:06 am EDT

Jeevan Scientific Technology Limited informed that Mr. M. Srikanth Sasidhar, CFO has vide letter dated 06.07.2022 has tendered his resignation from the post of Chief Financial Officer which is subject to the approval of the Board in its next meeting.

Latest news about Jeevan Scientific Technology Limited

Jeevan Scientific Technology Limited Announces Executive Changes, Effective March 31, 2024	Mar. 11	CI
US FDA Clears Jeevan Scientific Technology's Bioanalytical Plant in Hyderabad, India	Feb. 26	MT
Jeevan Scientific Technology Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 13	CI
Jeevan Scientific Arm Ties Up with Aditri Pharm Sciences for Pharmaceutical Preparations	23-10-18	MT
Jeevan Scientific Technology Limited Announces Cessation of Surapaneni Sree Rama Koteswara Rao as Independent Director	23-09-29	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Jeevan Scientific Technology Limited Announces Resignation of Rama Krishna Prasad Kakarala as Non- Executive Director	23-08-12	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-27	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-08	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-08	CI
Nayas Laboratories Private Limited announced that it has received $20 million in funding from Jeevan Scientific Technology Limited	23-02-02	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-11	CI
Jeevan Scientific Technology Limited Declares Dividend for the Financial Year Ended March 31, 2022	22-09-29	CI
Jeevan Scientific Technology Names New CFO	22-08-14	MT
Jeevan Scientific Technology Limited Announces Executive Changes, Effective September 16, 2022	22-08-12	CI
Jeevan Scientific Technology Limited Appoints K. Jeevan Krishna as Executive Director	22-08-12	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-12	CI
Jeevan Scientific Technology Appoints New COO	22-08-04	MT
Jeevan Scientific Technology Limited Appoints Chakrapani Majumdar as Chief Operating Officer	22-08-04	CI
Jeevan Scientific Technology CFO Steps Down	22-07-06	MT
Jeevan Scientific Technology Limited Announces Resignation of Srikanth Sasidhar as Chief Financial Officer	22-07-06	CI
Jeevan Scientific Technology Limited Recommends Final Dividend	22-05-30	CI
Jeevan Scientific Technology Limited Announces Management Changes	22-03-25	CI
Jeevan Scientific Technology Limited Approves the Change in Designation of Jeevan Krishna Kuchipudi from Non-Executive Director to Executive Director	22-02-14	CI

Chart Jeevan Scientific Technology Limited

Duration

Period

Chart Jeevan Scientific Technology Limited

More charts

Company Profile

Jeevan Scientific Technology Limited is an India-based company, which provides technology-driven services and solutions to its clients across the globe. The Companyâs service portfolio enables its clients to provide an integrated solution for the management of clinical data from its inception to completion. The Company offers a range of clinical trial services from Phase II to IV for pharmaceutical, biotechnology and medical device to bring new drugs and devices into global reach faster. It also provides its services to other areas, such as cosmetics and nutraceuticals. Its clinical trial services include medical writing, clinical trial management, clinical trial monitoring, drug safety management, clinical data management, biostatistics and statistical programming, and quality assurance. It offers comprehensive pharmacovigilance and safety monitoring services from early development support through post-approval initiatives.

Sector

Biotechnology & Medical Research

Calendar

2024-08-12 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
JEEVAN SCIENTIFIC TECHNOLOGY LIMITED	-19.24%	9.19M
MODERNA, INC.	+43.36%	54.64B
IQVIA HOLDINGS INC.	-5.31%	39.92B
LONZA GROUP AG	+37.52%	38.82B
ICON PUBLIC LIMITED COMPANY	+14.75%	26.86B
CELLTRION, INC.	-12.56%	26.22B
ALNYLAM PHARMACEUTICALS, INC.	-22.45%	18.78B
UNITED THERAPEUTICS CORPORATION	+25.12%	12.21B
BIO-TECHNE CORPORATION	+0.04%	12.16B
MEDPACE HOLDINGS, INC.	+26.04%	11.94B

Other Biotechnology & Medical Research